Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $95

Benzinga · 10/31/2025 15:43
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $90 to $95.